查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519370

2024-2032 年按产品类型、给药途径、剂型、配销通路和地区分類的非处方药市场报告

Over The Counter Drugs Market Report by Product Type, Route of Administration, Dosage Form, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2023年全球非处方药（OTC）IMARC Group规模达1,687亿美元。

非处方药 (OTC) 也称为非处方药，无需处方或无需寻求医疗保健专业人员的治疗即可使用。它们安全有效，有助于治疗疼痛、咳嗽和感冒、腹泻、便秘、痤疮，并控制反覆发作的偏头痛和过敏。目前，它们在全球各地的药局、便利商店、超市和加油站均有贩售。

非处方 (OTC) 药品市场趋势：

越来越多地使用非处方药来治疗个人小病是推动市场成长的关键因素之一。除此之外，抗酸剂、组织胺 2 (H2) 阻断剂和质子帮浦抑制剂 (PPI) 等非处方药可用于缓解和预防胃灼热或酸性消化不良。此外，由于冠状病毒病（COVID-19）的爆发，人们对自我保健重要性的认识有所提高。这反过来又增加了营养补充剂的销售量并加强了市场成长。此外，主要参与者正在扩大其产品组合，以扩大其消费者基础并扩大其地理影响力。再加上监管机构越来越多地批准将处方药转向非处方药，正在对市场产生积极影响。除此之外，由于医疗费用增加，目前选择非处方药而不是咨询医生的人数增加。此外，自我药疗可以帮助控制慢性病，减少缺勤，并节省稀缺的医疗资源，以免在轻微情况下耗尽。其他一些因素，例如全球老年人口的增加、分销管道的快速扩张以及製药行业的显着增长，正在推动整体销售额和盈利能力。

本报告回答的关键问题

  • 2023 年全球非处方药 (OTC) 市场规模？
  • 2024-2032年全球非处方药（OTC）市场的预期成长率是多少？
  • 推动全球非处方药（OTC）市场发展的关键因素是什么？
  • COVID-19 对全球非处方药 (OTC) 市场有何影响？
  • 根据产品类型，全球非处方药 (OTC) 市场的细分情况如何？
  • 根据给药途径，全球非处方药 (OTC) 市场的细分如何？
  • 全球非处方药（OTC）市场按剂型划分是怎样的？
  • 全球非处方药 (OTC) 药品市场按配销通路划分是怎样的？
  • 全球非处方药（OTC）市场的主要区域有哪些？
  • 全球非处方 (OTC) 药品市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球非处方 (OTC) 药品市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 咳嗽、感冒和流感产品
    • 市场走向
    • 市场预测
  • 止痛药
    • 市场走向
    • 市场预测
  • 皮肤科产品
    • 市场走向
    • 市场预测
  • 肠胃产品
    • 市场走向
    • 市场预测
  • 维生素、矿物质和补充剂 (VMS)
    • 市场走向
    • 市场预测
  • 减肥/膳食产品
    • 市场走向
    • 市场预测
  • 眼科产品
    • 市场走向
    • 市场预测
  • 安眠药
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依管理途径

  • 口服
    • 市场走向
    • 市场预测
  • 注射用
    • 市场走向
    • 市场预测
  • 专题
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按剂型

  • 片剂和胶囊
    • 市场走向
    • 市场预测
  • 液体
    • 市场走向
    • 市场预测
  • 药膏
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 网路药局
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Alkem Laboratories Limited
    • Bayer AG
    • Daiichi Sankyo Company Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Novartis AG
    • Perrigo Company plc
    • Pfizer Inc.
    • Piramal Enterprises Ltd.
    • Reckitt Benckiser Group PLC
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A5189

The global over the counter (OTC) drugs market size reached US$ 168.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 275.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032.

Over the counter (OTC) drugs, also known as non-prescription drugs, can be used without a prescription or the need for seeking treatment by a healthcare professional. They are safe and effective and help cure pain, cough and cold, diarrhea, constipation, acne and manage recurring migraines and allergies. They are currently available in pharmacies, convenience stores, supermarkets and gas stations across the globe.

Over The Counter (OTC) Drugs Market Trends:

The increasing utilization of OTC drugs to treat minor ailments among individuals represents one of the key factors bolstering the market growth. Besides this, OTC medications, such as antacids, histamine-2 (H2) blockers, and proton pump inhibitors (PPIs), are used to relieve and prevent heartburn or acid indigestion. In addition, due to the coronavirus disease (COVID-19) outbreak, there is a rise in awareness among individuals about the importance of self-care. This, in turn, is increasing the sales of nutritional supplements and strengthening the market growth. Moreover, key players are expanding their product portfolio to widen their consumer base and increase their geographical presence. This, coupled with the increasing approvals from regulatory bodies for switching prescription drugs to OTC drugs, is positively influencing the market. Apart from this, there is currently an increase in the number of people opting for OTC drugs rather than consulting physicians on account of increasing healthcare costs. Furthermore, self-medication practices can assist in controlling chronic diseases, reducing absenteeism from work, and saving scarce medical resources from being exhausted during minor conditions. Some of the other factors, such as the rising geriatric population worldwide, rapid expansion of distribution channels, and significant growth in the pharmaceutical industry, are driving the overall sales and profitability.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global over the counter (OTC) drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, route of administration, dosage form, and distribution channel.

Breakup by Product Type:

Cough, Cold and Flu Products

Analgesics

Dermatology Products

Gastrointestinal Products

Vitamins, Minerals and Supplements (VMS)

Weight-loss/Dietary Products

Ophthalmic Products

Sleeping Aids

Others

Breakup by Route of Administration:

Oral

Parenteral

Topical

Others

Breakup by Dosage Form:

Tablets and Capsules

Liquids

Ointments

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alkem Laboratories Limited, Bayer AG, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1. What was the size of the global over the counter (OTC) drugs market in 2023?
  • 2. What is the expected growth rate of the global over the counter (OTC) drugs market during 2024-2032?
  • 3. What are the key factors driving the global over the counter (OTC) drugs market?
  • 4. What has been the impact of COVID-19 on the global over the counter (OTC) drugs market?
  • 5. What is the breakup of the global over the counter (OTC) drugs market based on the product type?
  • 6. What is the breakup of the global over the counter (OTC) drugs market based on the route of administration?
  • 7. What is the breakup of the global over the counter (OTC) drugs market based on the dosage form?
  • 8. What is the breakup of the global over the counter (OTC) drugs market based on the distribution channel?
  • 9. What are the key regions in the global over the counter (OTC) drugs market?
  • 10. Who are the key players/companies in the global over the counter (OTC) drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Over The Counter (OTC) Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Cough, Cold and Flu Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Analgesics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dermatology Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Gastrointestinal Products
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Vitamins, Minerals and Supplements (VMS)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Weight-loss/Dietary Products
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Ophthalmic Products
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Sleeping Aids
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Others
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Dosage Form

  • 8.1 Tablets and Capsules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Liquids
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ointments
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Alkem Laboratories Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Daiichi Sankyo Company Limited
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Dr. Reddy's Laboratories Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 GlaxoSmithKline plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Novartis AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Perrigo Company plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Piramal Enterprises Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Reckitt Benckiser Group PLC
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Sun Pharmaceutical Industries Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Teva Pharmaceutical Industries Ltd.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Over The Counter Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Over The Counter Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Over The Counter Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Over The Counter Drugs Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Over The Counter Drugs Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Over The Counter Drugs Market: Breakup by Dosage Form (in %), 2023
  • Figure 7: Global: Over The Counter Drugs Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Over The Counter Drugs Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Over The Counter Drugs (Analgesics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Over The Counter Drugs (Analgesics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Over The Counter Drugs (Dermatology Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Over The Counter Drugs (Dermatology Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Over The Counter Drugs (Gastrointestinal Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Over The Counter Drugs (Gastrointestinal Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Over The Counter Drugs (Ophthalmic Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Over The Counter Drugs (Ophthalmic Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Over The Counter Drugs (Sleeping Aids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Over The Counter Drugs (Sleeping Aids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Over The Counter Drugs (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Over The Counter Drugs (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Over The Counter Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Over The Counter Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Over The Counter Drugs (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Over The Counter Drugs (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Over The Counter Drugs (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Over The Counter Drugs (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Over The Counter Drugs (Other Route of Administrations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Over The Counter Drugs (Other Route of Administrations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Over The Counter Drugs (Tablets and Capsules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Over The Counter Drugs (Tablets and Capsules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Over The Counter Drugs (Liquids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Over The Counter Drugs (Liquids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Over The Counter Drugs (Ointments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Over The Counter Drugs (Ointments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Over The Counter Drugs (Other Dosage Forms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Over The Counter Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Over The Counter Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Over The Counter Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Over The Counter Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Over The Counter Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Over The Counter Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Over The Counter Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Over The Counter Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Over The Counter Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: North America: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: North America: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: United States: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: United States: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Canada: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Canada: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Asia-Pacific: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Asia-Pacific: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: China: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: China: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Japan: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Japan: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: India: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: India: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: South Korea: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: South Korea: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Australia: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Australia: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Indonesia: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Indonesia: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Europe: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Europe: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Germany: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Germany: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: France: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: France: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: United Kingdom: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: United Kingdom: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Italy: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Italy: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Spain: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Spain: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Russia: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Russia: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Latin America: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Latin America: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Brazil: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Brazil: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Mexico: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Mexico: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Others: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Middle East and Africa: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Middle East and Africa: Over The Counter Drugs Market: Breakup by Country (in %), 2023
  • Figure 99: Middle East and Africa: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Global: Over The Counter Drugs Industry: SWOT Analysis
  • Figure 101: Global: Over The Counter Drugs Industry: Value Chain Analysis
  • Figure 102: Global: Over The Counter Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Over The Counter Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Over The Counter Drugs Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Over The Counter Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Over The Counter Drugs Market Forecast: Breakup by Dosage Form (in Million US$), 2024-2032
  • Table 5: Global: Over The Counter Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Over The Counter Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Over The Counter Drugs Market: Competitive Structure
  • Table 8: Global: Over The Counter Drugs Market: Key Players